Molecular pathogenesis of human hepatocellular carcinoma.
Kern
Michael A
MA
Institute of Pathology, University of Cologne, Germany.
Breuhahn
Kai
K
Schirmacher
Peter
P
D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control / Q000821:virology; D002448:Cell Adhesion / Q000235:genetics; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D002908:Chronic Disease; D018816:Genes, cdc; D016158:Genes, p53; D006133:Growth Substances / Q000502:physiology; D016174:Hepacivirus / Q000472:pathogenicity; D006515:Hepatitis B virus / Q000472:pathogenicity; D019694:Hepatitis B, Chronic / Q000150:complications / Q000821:virology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000821:virology; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000473:pathology; D008113:Liver Neoplasms / Q000209:etiology* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control / Q000821:virology; D009361:Neoplasm Invasiveness / Q000235:genetics; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic / Q000235:genetics; D011230:Precancerous Conditions / Q000150:complications / Q000473:pathology
D006133:Growth Substances